No Detail Found!

Comparative Efficacy of Pharmacological Agents in the Ablation of Subcutaneous Insulinomas in Nude Mice Models

Author(s)
Nan Yi Department of Gastroenterology, The People's Hospital of Guangxi Zhuang Autonomous Region,Nanning,China
Fengping Chen Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. Guangxi Medical University, Nanning, China
Biaolin Zheng Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. Guangxi Medical University, Nanning, China
Wenwen Guo Department of Pathology, The People's Hospital of Guangxi Zhuang Autonomous Region,Nanning,China
Lin Yu Department of Animal Genetics and Breeding, Animal Science and Technology College, Guangxi University,Nanning,China
Shanyu Qin Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. Guangxi Medical University, Nanning, China.
Haixing Jiang Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. Guangxi Medical University, Nanning, China.
Abstract
Endoscopic ultrasound-guided local ablation therapy is one of the most important approaches for treating insulinomas that arise from neuroendocrine islet cell tumors located within the pancreas. This study aimed to evaluate the efficacy of various ablative treatments including anhydrous ethanol, lauromacrogol, polidocanol, and paclitaxel as local ablative agents on subcutaneous insulinoma tumors in mice models using tumor necrosis and drug distribution. For this purpose, mice were modeled for insulinoma tumors by subcutaneous injection of Ins-1 and Min-6 cell lines in 4-6 weeks-old nude female mice. The tumors became visible 1 to 2 weeks after the transplantation of cells, reaching a treatment-appropriate volume of 2030mm3 within 2 to 3 weeks, as confirmed by the insulinoma-like characteristics observed during histopathological analysis. The results indicated that the insulinoma animal models exhibited an early onset of hypoglycemia and significantly elevated serum insulin levels during starvation tests, compared to the control group further confirmed by expression of chromogranin A (CgA), synaptophysin (Syn), and insulinoma-associated protein 1 (Insm1) in the tumor cells during immunohistochemical staining. Following treatment, necrosis percentages in insulinoma tumors were significantly higher in the paclitaxel (93.2%) and ethanol (86.5%) groups compared to saline, polidocanol, and polyglactin groups. Similarly, tumor drug distribution was tracked using methylene blue, with paclitaxel demonstrating the fastest diffusion, followed by ethanol, polidocanol, and polyglactin. These findings suggest that both paclitaxel and polidocanol have significant potential as local ablative agents in inducing tumor necrosis, with paclitaxel offering the fastest drug dispersion. These results highlight the potential for further optimization of ablation therapies in insulinoma treatment.
Publication Details
Page(s) 1043-1052
Published Journal: Pakistan Veterinary Journal, Volume: 44, Issue: 4, Year: 2024

Request the full text from PASTIC

Keywords
Anhydrous ethanol Lauromacrogol Insulinoma Paclitaxel Polidocanol
References
An S,Sung Y N,Kim S J .2022 .Pancreatic Cysts after endoscopic ultrasonography-guided ethanol and/or paclitaxel ablation therapy: another mimic of pancreatic pseudocysts. Pathobiol, 89 : 49-55.
Ardeshna D R E,Tsung A .2022 .An update on EUS-guided ablative techniques for pancreatic cystic lesions. Endosc Ultrasound, 11 : 432-441.
Attila T,Adsay V,Faigel D O V .2019 .The efficacy and safety of endoscopic ultrasound-guided ablation of pancreatic cysts with alcohol and paclitaxel: a systematic review. Eur J Gastroenterol Hepatol, 31 : 1-9.
Bełtowski J,Wójcicka G,Jamroz-Wiśniewska A .2018 .Hydrogen sulfide in the regulation of insulin secretion and insulin sensitivity: Implications for the pathogenesis and treatment of diabetes mellitus. Biochem Pharmacol, 149 : 60-76.
Binici C,Plog S,Kershaw O .2016 .Insulinoma in a 5-Year-Old Dexter Cow. J Vet Intern Med, 30 : 1402-6.
Bollard J,Patte C,Massoma P .2018 .Combinatorial treatment with mTOR inhibitors and streptozotocin leads to synergistic in vitro and in vivo antitumor effects in insulinoma cells. Mol Cancer Ther, 17 : 60-72.
Buishand F O .2022 .Current Trends in Diagnosis, Treatment and Prognosis of Canine Insulinoma. Vet Sci, 9 : 540.
Canakis A,Law R,Baron T .2020 .An updated review on ablative treatment of pancreatic cystic lesions. Gastrointest Endosc, 91 : 520-526.
Chae H K J I,An J H J I .2020 .Use of oral paclitaxel for the treatment of bladder tumors in dogs. J Vet Med Sci, 82 : 527-530.
Chen F,Lu J,Zheng B .2024 .Artesunate inhibits the growth of insulinoma cells via SLC7A11/ GPX4-mediated Ferroptosis. Curr Pharm Des, 30 : 230-239.
Chen L,Bi Z X,Q C Z X .2021 .Ultrasound-guided percutaneous ethanol-paclitaxel combined therapy for rabbit VX2 liver tumors. J Hepatocell Carcinoma, 8 : 263-270.
Chick WL,Warren S,Chute RN .1977 .A transplantable insulinoma in the rat. Proc Natl Acad Sci U S A, 74 : 628-32.
Choi J H Park D H,Kim M H Park D H .2018 .Outcomes after endoscopic ultrasound-guided ethanol-lipiodol ablation of small pancreatic neuroendocrine tumors. Dig Endosc, 30 : 652-658.
Collantes M,Barajas M,Quincoces G .2017 .Lessons from 11Cdihydrotetrabenazine imaging in a xenograft mouse model of rat insulinoma: is PET imaging of pancreatic beta cell mass feasible?. Q J Nucl Med Mol Imaging, 61 : 447-455.
Crinò S F B,Facciorusso A .2023 .Endoscopic ultrasound-guided radiofrequency ablation versus surgical resection for treatment of pancreatic insulinoma. Clin Gastroenterol Hepatol, 21 : 2834-2843.
de Herder WW,Niederle B,Scoazec J Y B .2006 .Well-differentiated pancreatic tumor/carcinoma: insulinoma. Neuroendocrinol, 84 : 83-8.
Detour J,Pierre A,Boisson F .2017 .Effect of Carbidopa on 18FFDOPA uptake in insulinoma: From cell culture to small-animal PET imaging. J Nucl Med, 58 : 36-41.
Eso Y,Shimizu H,Takai A .2022 .Ultrasound-guided polidocanol foam sclerotherapy for symptomatic giant hepatic cyst: A singlecenter experience. Hepatol Res, 52 : 557-565.
Foxx J,Mans C,Strunk A .2022 .Long-term medical management of insulinoma in a rabbit (Oryctolagus cuniculus). J Exot Pet Med, 42 : 47-49.
Gaballa D,Abendroth C S and Moyer M T .2019 .Alcohol-free EUS-guided chemoablation of multiple pancreatic insulinomas. Endosc Int Open, 7 : E186-e188.
Gallo G,Pietroletti R,Novelli E .2022 .A multicentre, open-label, single-arm phase II trial of the efficacy and safety of sclerotherapy using 3% polidocanol foam to treat second-degree haemorrhoids (SCLEROFOAM). Tech Coloproctol, 26 : 627-636.
Gao F,Li H,Feng X .2023 .Cystic tumor ablation with different concentrations of lauromacrogol solution in an animal model. Minerva Gastroenterol (Torino)., : .
Gómez Ochoa P,Alférez M D,de Blas I .2021 .Ultrasound-Guided radiofrequency ablation of chemodectomas in five dogs. Anim, 11 : 2790.
Greene S N and Bright R M, . .Insulinoma in a cat. J Small Anim Pract, 49 : 38-40.
Hawks D,Peterson ME,Hawkins KL .1992 .Insulin-secreting pancreatic (islet cell) carcinoma in a cat. J Vet Intern Med, 6 : 193-6.
Hendricks-Wenger A,Arnold L,Gannon J .2022 .Histotripsy ablation in preclinical animal models of cancer and spontaneous tumors in veterinary patients: A Review. IEEE Trans Ultrason Ferroelectr Freq Control, 69 : 5-26.
Ravich Hess L R,Reavill D R M L .2013 .Diagnosis and treatment of an insulinoma in a guinea pig (Cavia porcellus). J Am Vet Med Assoc, 242 : 522-6.
Jilesen A P C H .2016 .Postoperative complications, in-hospital mortality and 5-year survival after surgical resection for patients with a pancreatic neuroendocrine tumor:A Systematic Review. World J Surg, 40 : 729-48.
Mageed M,Steinberg T,Maleas G .2023 .Diagnostic imaging and conservative management of an ultimobranchial thyroid cyst in an adult horse. Equine Vet Educ, 35 : e14-e20.
Matsumoto K and Kato H .2023 .Endoscopic ablation therapy for the pancreatic neoplasms. Dig Endosc, 35 : 430-442.
Mehrabi A,Fischer L,Hafezi M .2014 .A systematic review of localization, surgical treatment options, and outcome of insulinoma. Pancreas, 43 : 675-86.
Min X,Zhang Z,Chen Y .2023 .Comparison of the effectiveness of lauromacrogol injection for ablation and microwave ablation in the treatment of predominantly cystic thyroid nodules: a multicentre study. BMC Cancer, 23 : 785.
Miwa Y,Kurosawa A,Ogawa H .2009 .Neoplasitic diseases in ferrets in Japan: a questionnaire study for 2000 to 2005. J Vet Med Sci, 71 : 397-402.
Moyer M T,Dye C E,Sharzehi S .2016 .Is alcohol required for effective pancreatic cyst ablation? The prospective randomized CHARM trial pilot study. Endosc Int Open, 4 : E603-7.
Moyer M T,Sharzehi S,Mathew A .2017 .The safety and efficacy of an alcohol-free pancreatic cyst ablation protocol. Gastroenterol, 153 : 1295-1303.
Oh H C D W,Lee T Y .2008 .New treatment for cystic tumors of the pancreas: EUS-guided ethanol lavage with paclitaxel injection. Gastrointest Endosc, 67 : 636-42.
Oh H C D W,Song T J .2011 .Endoscopic ultrasonographyguided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts. Gastroenterol, 140 : 172-9.
Qin S Y,Lu X P and Jiang H X .2014 .EUS-guided ethanol ablation of insulinomas: case series and literature review. Medicine (Baltimore), 93 : e85.
Qin S,Liu Y,Ning H .2018 .EUS-guided lauromacrogol ablation of insulinomas: a novel treatment. Scand J Gastroenterol, 53 : 616-620.
Ryan D,Pérez-Accino J,Gonçalves R .2009 .Clinical findings, neurological manifestations and survival of dogs with insulinoma: 116 cases (. J Small Anim Pract, 62 : 531-539.
Schoemaker NJ .2021 .. Exotic Animal Emerg Crit Care Med 201-237., : .
Schubert U,Schmid J,Lehmann S .2013 .Transplantation of pancreatic islets to adrenal gland is promoted by agonists of growth-hormone-releasing hormone. Proc Natl Acad Sci U S A, 110 : 2288-93.
Howe Scott A T,J R Scott A T .2019 .Evaluation and management of neuroendocrine tumors of the pancreas. Surg Clin North Am, 99 : 793-814.
Miller W W and Almond Stuckey J A,G T Stuckey J A .2012 .Use of a sclerosing agent (1% polidocanol) to treat an orbital mucocele in a dog. Vet Ophthalmol, 15 : 188-93.
Tsang YP,Lang BH,Shek TW .2016 .Assessing the short- and longterm outcomes after resection of benign insulinoma. ANZ J Surg, 86 : 706-10.
Varela D,Yu A,Saxon D .2018 .Insulinoma masquerading as transient neurocognitive impairment. Am J Med, 131 : e377-e379.
Jin Yang J I,Kim B,S Y B .2020 .Antitumour effects of Liporaxel (oral paclitaxel) for canine melanoma in a mouse xenograft model. Vet Comp Oncol, 18 : 152-160.
Yau W and Rissi D R .2014 .Cholecystic adenocarcinoma and pancreatic insulinomas in a goat. J Vet Diagn Invest, 26 : 827-31.
Zheng B,Chen X,Chen F .2023 .-Iodotubercidin Inhibits the Growth of Insulinoma Cells by Inducing Apoptosis. Neuroendocrinol, 113 : 641-656.
0

Citations

0

Downloads

40

Views